Objective To update and expand upon prior Osteoarthritis Research Society International
(OARSI) guidelines by developing patient-focused treatment recommendations for …

OBJECTIVE: To update evidence for available therapies in the treatment of hip and knee
osteoarthritis (OA) and to examine whether research evidence has changed from 31 …

Knee osteoarthritis (KOA) is a common chronic debilitating disease with an estimated
prevalence of 23.9% in the general adult population. The condition is characterised by joint …

Background Use of topical nonsteroidal anti‐inflammatory drugs (NSAIDs) to treat chronic
musculoskeletal conditions has become widely accepted because they can provide pain …

Objectives To compare the efficacy and safety of topical non-steroidal anti-inflammatory
drugs (NSAIDs), including salicylate, for the treatment of osteoarthritis (OA). Methods …

Oral analgesics are commonly prescribed for the treatment of acute and chronic pain, but
these agents often produce adverse systemic effects, which sometimes are severe. Topical …

Abstract Purpose The Western Ontario and McMaster Universities Arthritis Index (WOMAC)
is a commonly used outcome measure for osteoarthritis. There are different versions of the …

Knee pain is second only to the back as the most commonly reported area of pain in the
human body. With an overall prevalence of 46.2%, its impact on disability, lost productivity …

Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used in the treatment of pain
associated with a variety of indications, including arthritic conditions, but their usefulness is …

Background There is limited information on the costs and benefits of alternative adjunct non-
pharmacological treatments for knee osteoarthritis and little guidance on which should be …